A preliminary study on ultrasound-guided percutaneous microwave ablation for palliative treatment of advanced head and neck malignancies

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Pan R, Zhu M, Yu C, et al., China Kadoorie Biobank Collaborative Group. Cancer incidence and mortality: a cohort study in China, 2008–2013. Int J Cancer. 2017;141(7):1315–1323.
   PubMed Web of Science ®Google Scholar
• Vokes EE, Weichselbaum RR, Lippman SM, et al. Head and neck cancer. N Engl J Med. 1993;328(3):184–194.
   PubMed Web of Science ®Google Scholar
• Maruo T, Zenda S, Shinozaki T, et al. Comparison of salvage surgery for recurrent or residual head and neck squamous cell carcinoma. Jpn J Clin Oncol. 2020;50(3):288–295.
   PubMed Web of Science ®Google Scholar
• Hamoir M, Schmitz S, Suarez C, et al. The current role of salvage surgery in recurrent head and neck squamous cell carcinoma. Cancers. 2018;10(8):267.
   Web of Science ®Google Scholar
• Tupchong L, Scott CB, Blitzer PH, et al. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03. Int J Radiat Oncol Biol Phys. 1991;20(1):21–28.
   PubMed Web of Science ®Google Scholar
• Kao J, Garofalo MC, Milano MT, et al. Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review. Cancer Treat Rev. 2003;29(1):21–30.
   PubMed Web of Science ®Google Scholar
• Vermorken JB, Stöhlmacher-Williams J, Davidenko I, et al. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial. Lancet Oncol. 2013;14(8):697–710.
   PubMed Web of Science ®Google Scholar
• Moskovitz J, Moy J, Ferris RL. Immunotherapy for head and neck squamous cell carcinoma. Curr Oncol Rep. 2018;20(2):1033–1043.
   Web of Science ®Google Scholar
• Echarri M, Lopez-Martin A, Hitt R. Targeted therapy in locally advanced and recurrent/metastatic head and neck squamous cell carcinoma (LA-R/M HNSCC). Cancers. 2016;8(3):27.
   Web of Science ®Google Scholar
• Bredlau AL, Mccrackin MA, Motamarry A, et al. Thermal therapy approaches for treatment of brain tumors in animals and humans. Crit Rev Biomed Eng. 2016;44(6):443–457.
   PubMed Web of Science ®Google Scholar
• Webb H, Lubner MG, Hinshaw JL. Thermal ablation. Semin Roentgenol. 2011;46(2):133–141.
   PubMed Web of Science ®Google Scholar
• Yue W, Wang S, Yu S, et al. Ultrasound-guided percutaneous microwave ablation of solitary T1N0M0 papillary thyroid microcarcinoma: initial experience. Int J Hyperthermia. 2014;30(2):150–157.
   PubMed Web of Science ®Google Scholar
• Olaitan A, Mould T. Successful microwave ablation of endometrial carcinoma. Bjog. 2003;110(8):1410–1412.
   Web of Science ®Google Scholar
• Yang W, Ping L, Xiaoling Y, et al. Ultrasound-guided percutaneous microwave ablation of adrenal metastasis: preliminary results. Int J Hyperthermia. 2009;25(6):455–461.
   PubMed Web of Science ®Google Scholar
• Leng S, Christner JA, Carlson SK, et al. Radiation dose levels for interventional CT procedures. AJR Am J Roentgenol. 2011;197(1):W97–W103.
   PubMed Web of Science ®Google Scholar
• Jong RJBD, Rongen RJ, Laméris JS, et al. Metastatic neck disease. Palpation vs ultrasound examination. Arch Otolaryngol Head Neck Surg. 1989;115(6):689–690.
   PubMedGoogle Scholar
• Senchenkov A, Staren ED. Ultrasound in head and neck surgery: thyroid, parathyroid, and cervical lymph nodes. Surg Clin North Am. 2004;84(4):973–1000.
   PubMed Web of Science ®Google Scholar
• Yeh MW, Bauer AJ, Bernet VA, et al., American Thyroid Association Surgical Affairs Committee Writing Task Force. American Thyroid Association Statement on Preoperative Imaging for Thyroid Cancer Surgery. Thyroid. 2015;25(1):3–14.
   PubMed Web of Science ®Google Scholar
• Hassan SJ, Weymuller EA. Assessment of quality of life in head and neck cancer patients. Head Neck. 1993;15(6):485–496.
   PubMed Web of Science ®Google Scholar
• Nwizu T, Adelstein D. Pharmacotherapy of head and neck cancer. Expert Opin Pharmacother. 2015;16(16):1–14.
   PubMed Web of Science ®Google Scholar
• Chen JH, Yen YC, Liu SH, et al. Outcomes of induction chemotherapy for head and neck cancer patients: a combined study of two national cohorts in Taiwan. Medicine. 2016;95(7):e2845.
   PubMed Web of Science ®Google Scholar
• Wong SJ, Machtay M, Li Y. Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone? J Clin Oncol. 2006;24(17):2653–2658.
   PubMed Web of Science ®Google Scholar
• Singh NY, Shalini S, Ranjan DN. Chemo-reirradiation in persistent/recurrent head and neck cancers. Jpn J Clin Oncol. 2004;34(2):61–68.
   PubMed Web of Science ®Google Scholar
• Cacicedo J, Navarro A, Alongi F, et al. The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach. Cancer Treat Rev. 2014;40(1):178–189.
   PubMed Web of Science ®Google Scholar
• Lee N, Chan K, Bekelman JE, et al. Salvage re-irradiation for recurrent head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;68(3):731–740.
   PubMed Web of Science ®Google Scholar
• Lee GM, You JY, Kim HY, et al. Successful radiofrequency ablation strategies for benign thyroid nodules. Endocrine. 2019;64(2):316–321.
   PubMed Web of Science ®Google Scholar
• Biamonte E, Solbiati L, Ierace T, et al. Medullary thyroid carcinoma treated with percutaneous ultrasound-guided radiofrequency ablation. Endocrine. 2019;65(3):515–519.
   PubMed Web of Science ®Google Scholar
• Trimboli P, Pelloni F, Bini F, et al. High-intensity focused ultrasound (HIFU) for benign thyroid nodules: 2-year follow-up results. Endocrine. 2019;65(2):312–317.
   PubMed Web of Science ®Google Scholar
• Roberto N, Gabriele G. Percutaneous ethanol injection in combination with laser ablation for a 100 ml partially cystic thyroid nodule. Case Rep Endocrinol. 2018;2018:8046378.
   PubMed Web of Science ®Google Scholar
• Brook AL, Gold MM, Miller TS, et al. CT-guided radiofrequency ablation in the palliative treatment of recurrent advanced head and neck malignancies. J Vasc Interv Radiol. 2008;19(5):725–735.
   PubMed Web of Science ®Google Scholar
• Belfiore MP, Sciandra M, Romano F, et al. Preliminary results in unresectable head and neck cancer treated by radiofrequency and microwave ablation: feasibility, efficacy, and safety. J Vasc Interv Radiol. 2015;26(8):1189–1196.
   PubMed Web of Science ®Google Scholar
• Wang L, Ge M, Xu D, et al. Ultrasonography-guided percutaneous radiofrequency ablation for cervical lymph node metastasis from thyroid carcinoma. J Can Res Ther. 2014;10(7):144–149.
   Web of Science ®Google Scholar
• Owen RP, Lee JS, Silver CE, et al. Radiofrequency ablation in advanced head and neck cancer. Eur Arch Otorhinolaryngol. 2014;271(2):207–210.
   PubMed Web of Science ®Google Scholar
• Bäck LJJ, Mäkitie AA, O'Malley BW, et al. When is radiofrequency ablation not indicated in head and neck squamous cell carcinoma management? Eur Arch Otorhinolaryngol. 2015;272(5):1045–1046.
   PubMed Web of Science ®Google Scholar
• Zhou W, Chen Y, Zhang L, et al. Percutaneous microwave ablation of metastatic lymph nodes from papillary thyroid carcinoma: preliminary results. World J Surgery. 2019;434(4):1029–1037.
   Web of Science ®Google Scholar
• Kalra A, Prucher G, Hodges S. The role of core needle biopsies in the management of neck lumps. Ann R Coll Surg Engl. 2019;101(3):193–196.
   PubMed Web of Science ®Google Scholar
• Han F, Xu M, Xie T, et al. Efficacy of ultrasound-guided core needle biopsy in cervical lymphadenopathy: a retrospective study of 6,695 cases. Eur Radiol. 2018;28(5):1809–1817.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Xu X, Ding J, et al. Dynamic changes of T-cell subsets and their relation with tumor recurrence after microwave ablation in patients with hepatocellular carcinoma. J Cancer Res Ther. 2018;14(1):40–45.
   PubMed Web of Science ®Google Scholar
• Chung SR, Baek JH, Choi YJ, et al. Management strategy for nerve damage during radiofrequency ablation of thyroid nodules. Int J Hyperthermia. 2019;36(1):203–209.
   Web of Science ®Google Scholar